Human noroviruses (HuNoVs) are an important cause of epidemic and endemic acute 21 gastroenteritis worldwide; annually about 700 million people develop a HuNoV infection resulting 22 in ~219,000 deaths and a societal cost estimated at 60 billion US dollars 1 . The lack of robust small 23 animal models has significantly hindered the understanding of norovirus biology and the 24 development of effective therapeutics against HuNoV. Here we report that HuNoV GI and GII 25 replicate to high titers in zebrafish (Danio rerio) larvae; replication peaks at day 2 post infection 26 and is detectable for at least 6 days. HuNoV is detected in cells of the hematopoietic lineage, the 27 intestine, liver and pancreas. Antiviral treatment reduces HuNoV replication by >2 log10, showing 28 that this model is suited for antiviral studies. Downregulation of fucosyltransferase 8 (fut8) in the 29 larvae reduces HuNoV replication, highlighting a common feature with infection in humans. 30 Zebrafish larvae constitute a simple and robust replication model that will largely facilitate studies 31 of HuNoV biology and the development of antiviral strategies. 32 Large outbreaks of norovirus gastroenteritis are frequent and have a significant impact in terms of 33 morbidity, mortality and health care costs, in particular in hospital wards and nursing homes. 34 Chronic norovirus infections present a problem for a large group of immunodeficient patients, who 35 may present with diarrhea for several months. Furthermore, in countries where routine rotavirus 36 vaccination has been implemented, noroviruses are the most common cause of severe childhood 37 diarrhea resulting in important morbidity and mortality 2 . Knowledge on the biology and 38 pathogenesis of human noroviruses largely depends upon the development of robust and 39 physiologically relevant cultivation systems. A number of such model systems have been reported 40 in recent years but still carry important limitations. HuNoV replication has been reported in large 41
cell-derived enteroids. [7] [8] [9] There is thus an urgent need for simpler, more robust, widely available 48 HuNoV replication models. Such models should contribute to a better understanding of the biology 49 of HuNoV replication and infection, this will significantly facilitate larger-scale research efforts, 50 such as the development of therapeutic strategies.
51
Zebrafish (Danio rerio) are optically-transparent tropical freshwater fish of the family Cyprinidae 52 that are widely used as vertebrate models of disease. They have remarkable genetic, physiologic 53 and pharmacologic similarities to humans. Compared to rodents, the maintenance and husbandry 54 costs are very low. Zebrafish have high fecundity and using their offspring is in better compliance 55 with the 3Rs principles of humane animal experimentation (EU Directive 2010/63/EU). The 56 immune system of zebrafish is comparable to that of humans; there are B and T cells, macrophages, 57 neutrophils and a comparable set of signaling molecules and pathways 10 . Whereas innate immunity 58 is present at all developmental stages, adaptive immunity develops after 4-6 weeks of life 11,12 . 59 Host-pathogen interactions can be studied, as zebrafish are naturally infected by multiple bacteria, 60 protozoa and viruses that affect mammals 11 . Infection of zebrafish larvae has been shown with 61 various pathogens including Mycobacterium 13 , some human viruses (herpes simplex 1, influenza 62 A, hepatitis C and chikungunya viruses) 14-17 and enteric bacteria, e.g. E. coli, Listeria, Salmonella,
63
Shigella and Vibrio 11 . The intestinal tract of zebrafish is comprised of large folds of an epithelial 64 lining, a lamina propria containing immune cells and underlying smooth muscle layers 18 .
65
Enterocytes, goblet cells, enteroendocrine cells, and possibly M-cells are present, but not Paneth 66 cells or Peyer's patches 12 . Intestinal tuft cells, which were recently shown to be a target cell for the mouse norovirus (MNV) 19 , have been described in teleost fish thus are likely present in 68 zebrafish. There is an intestinal bulb (instead of a stomach) and a mid-and posterior intestine 18 .
69
Epithelial cells show a high-turnover from base to tip, with intestinal epithelial stem cells at the 70 base and apoptotic cells at the tips 18 . A resident commensal microbiota is present (comprising most 71 bacterial phyla of mammals) and serve analogous functions in the digestive tract 11, 18 . Here we 72 report a robust replication model of HuNoV in zebrafish larvae.
73
Zebrafish larvae were infected with a PBS suspension of a HuNoV positive stool sample at 3 days 74 post-fertilization (dpf). At this time point, zebrafish larvae have hatched and organs are formed 75 (including the full length gastrointestinal tract). Three nL, containing 3.4x10 6 viral RNA copies of 76 HuNoV GII.P7-GII.6 (1.1x10 13 RNA copies/g of stool), were injected in the yolk of the larvae 77 (which provides nutrition during early larval stage). Each day post infection (pi), the general 78 condition of the zebrafish larvae was assessed microscopically and these were harvested in groups 79 of 10 for viral RNA quantification by RT-qPCR 16 . To detect input virus, in every independent 80 experiment, 10 larvae were harvested at day 0 pi (specifically 1 h pi). A maximum increase of ~2.5 81 log10 in viral RNA copies compared to day 0 was detected at day 2 pi ( Fig. 1A) ; high levels of viral 82 RNA remained detectable for at least 6 days pi ( Fig. 1A, S1 ). When larvae were injected with 3 nL 83 of UV-inactivated HuNoV GII.P7-GII.6, no increase in viral RNA titers was detected ( Fig. 1A ).
84
No obvious signs of distress or disease were observed as a result of the infection (e.g. changes in 85 posture, swimming behavior or signs of edema). To determine the 50% infectious dose (ID50) for 86 this strain, larvae were infected with 10-fold dilution series of the virus (Fig. 1B) . The ID50 was 87 calculated to be 1.8 x 10 3 viral RNA copies. HuNoV antigens were detected using the commercial 88 enzyme immunoassay (EIA) RIDASCREEN (R-Biopharm), in HuNoV GII.P7-GII.6-infected 89 zebrafish larvae harvested at day 3 pi (Fig. 1C ). We next investigated the innate immune response 90 of 3 dpf larvae to a HuNoV infection. An increased expression of ifn, mx and rsad2/viperin mRNA 91 was detected, with a 7-fold, 23-fold and 105-fold maximum increase, respectively, when compared 92 to control inoculated larvae ( Fig. 1D ). This level of upregulation is in line with the observed 93 induction of the IFN response following an influenza A infection of zebrafish larvae 16 . These same Next, infected larvae were treated with a broad-spectrum antiviral, i.e. the viral polymerase 122 inhibitor 2'-C-methylcytidine (2CMC) of which we showed earlier inhibition of MNV replication 123 in vitro and in mice 22,23 , by immersion (whereby the molecule was added to the water). A 2.4 log10 124 reduction in viral RNA titers was observed at the peak of replication (Fig. 1E ). The fact that 125 replication can be significantly reduced with an inhibitor of the viral polymerase, provides further 126 evidence that HuNoV replicates efficiently in zebrafish larvae and that the model is suitable for 127 antiviral drug development.
128
One of the hurdles to develop robust replication models for HuNoV is the need to use a stool sample 129 of an infected patient as inoculum. In order to rule out any potential impact of other agents present Table S1 ) and did not affect the kinetics of virus replication in larvae ( Fig. S2B-D) .
137
Infection of zebrafish larvae with other HuNoV genotypes was next performed. Infection with the 138 HuNoV GII.P4 New Orleans-GII.4 Sydney strain, recovered from stool samples of two different 139 patients, resulted in a >3 log10 increase in viral replication in both cases. A maximum of ~10 7 viral 140 RNA copies/10 zebrafish larvae was detected at day 2 pi ( Fig. 2A) , the highest observed in this 141 model 6, 8, 9 . Viral non-structural and structural antigens were detected by western blot (Fig. 2B, Fig.   142 S3) and by EIA ( Fig. 2C) , respectively. Viral antigens were no longer detected by EIA in 2CMC-143 treated HuNoV GII.4-infected larvae (Fig. 2C ). Infection with HuNoV GII.P16-GII.2 (Fig. 2D ) 144 and GII.P16-GII.3 ( Fig. 2E ) yielded increasing viral RNA titers, although the replication kinetics 145 of GII.P16-GII.3 was slower than that observed for the other genotypes. Slower kinetics of HuNoV 146 GII.3 replication was also observed in stem-cell-derived enteroids 9 . A GI HuNoV, specifically 147 GI.P7-GI.7, replicated with comparable kinetics to GII viruses (Fig. 2F ). Infection of zebrafish larvae with MNV (genogroup V) yielded no productive infection (Fig. S4) , 170 most likely due to the fact that the receptors CD300lf and CD300ld are not encoded by zebrafish 171 25 . Since HuNoV infections typically occur via the oral route, we next attempted to infect larvae 172 via immersion. No consistent increase in viral replication was noted up to day 5 pi (data not shown).
173
To determine the preferential site of replication of HuNoV in zebrafish larvae, HuNoV GII.P7-174 GII.6-infected larvae were dissected at day 3 pi in 4 different parts (yolk, head, body and tail). Viral
175
RNA titers were detected in every part (Fig. 3A) , whereby the yolk (the initial site of inoculation) 176 had the lowest titers, implying that HuNoV disseminates past the yolk and intestine. To investigate 177 which tissues are infected, sagittal and coronal histological sections of larvae infected with HuNoV 178 GII.P7-GII.6 were stained with HuNoV VP1-specific antibodies (Fig. 3B, Fig. S5-6 ). Viral 179 antigens were frequently detected in the intestinal bulb, pancreas and liver. A strong signal was 180 observed in the caudal hematopoietic tissue (CHT), which contains hematopoietic stem/progenitor 181 cells (HSPCs) that differentiate into multiple blood lineages and by 4 dpf start to migrate to the 182 kidney marrow and thymus 26 . This migration may explain why HuNoV was detected in every 183 section of the larvae. HuNoV has been detected in the intestine and liver of chimpanzees 3 , and has 184 as well been reported to replicate in cells of hematopoietic lineage 27 .
185
The HuNoV capsid binds to fucose-containing histo-blood group antigens (HBGAs), which are 186 key players in determining susceptibility to infection 28 . Fucosyltransferase (FUT) 2 and 3 genes 187 determine the addition of terminal fucose residues to HBGAs; individuals with a null FUT2 allele 188 are known to be resistant to infection with many HuNoV strains 29 . Zebrafish have fut7-11 genes, 189 of which the fut8 gene has the highest similarity between human, mice and zebrafish, and is the 190 only fut gene that is expressed in tissues that are relevant to a norovirus infection (Table S2 ). Fut8 191 is the single enzyme responsible for adding core fucose (α-1,6-Fuc) both in zebrafish and 192 mammals. When fut8 expression was knocked-down by injection of fut8 targeting morpholino 193 (MO) antisense oligonucleotides (Fig. S7 ), lower levels of HuNoV and a slower kinetics of 194 replication was observed, as compared to those injected with a control MO (Fig. 3) . This 195 demonstrates that fut8 is involved in susceptibility of zebrafish to HuNoV. We hypothesize that In conclusion, here we describe a robust and very convenient HuNoV replication model in stool aliquot (with a high virus titer) is sufficient to inject about 300,000 larvae, yielding 30,000+ 230 data points. The ability to generate large and homogenous datasets is essential for large-scale 231 efforts such as the development of therapeutics. This model, here validated for antiviral drug 232 studies using GI and GII HuNoVs, now allows to readily assess the potential antiviral activity of
